Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Reed's, Inc.
Reed's, Inc. News
Reed's, Inc. Quantitative Score
About Reed's, Inc.
Reed's, Inc. engages in the manufacture and distribution of natural hand-crafted beverages in the craft specialty foods industry in the United States, Canada, Asia, Europe, Australia, and South America. It offers Reed's craft ginger beers; Reed's real ginger ales; Reed's ready to drink products; Virgil's handcrafted sodas; ginger candy; and other ginger beverages under the Reed's brand. Reed's, Inc. sells its products to natural food and gourmet retailers, grocery store chains, mass merchants, club stores, convenience and drug stores, liquor stores, industrial cafeterias, and on-premise bars and restaurants through distributors and independent distributor partners, as well as direct to store distribution. It also exports its products to France, the United Kingdom, South Africa, the Caribbean, Canada, Spain, the Philippines, Israel, Australia, Asia, rest of Europe, and South America. The company was formerly known as Original Beverage Corporation and changed its name to Reed's, Inc. in 2001. Reed's, Inc. was founded in 1987 and is headquartered in Norwalk, Connecticut.
Reed's, Inc. Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
Reed's, Inc. Financials
Table Compare
Compare REED metrics with: | |||
|---|---|---|---|
Earnings & Growth | REED | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | REED | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | REED | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | REED | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Reed's, Inc. Income
Reed's, Inc. Balance Sheet
Reed's, Inc. Cash Flow
Reed's, Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Strong Sell |
| Return on Equity | Strong Sell |
| Return on Assets | Strong Sell |
| Debt/Equity Ratio | Neutral |
| Price/Earnings Ratio | Strong Sell |
| Price/Book Ratio | Strong Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Historical Market Cap
Shares Outstanding
Reed's, Inc. Executives
| Name | Role |
|---|---|
| Ms. Joann Christine Tinnelly CPA | Chief Accounting Officer & Secretary |
| Mr. Christopher Burleson | Chief Commercial Officer |
| Mr. Christopher J. Reed | Founder |
| Mr. Douglas W. McCurdy | Chief Financial Officer |
| Mr. Cyril Wallace | Chief Executive Officer & Director |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Ms. Joann Christine Tinnelly CPA | Chief Accounting Officer & Secretary | Female | 1970 | 385.14K |
| Mr. Christopher Burleson | Chief Commercial Officer | Male | 1983 | 327.7K |
| Mr. Christopher J. Reed | Founder | Male | 1958 | 141.88K |
| Mr. Douglas W. McCurdy | Chief Financial Officer | Male | -- | |
| Mr. Cyril Wallace | Chief Executive Officer & Director | Male | -- |
Reed's, Inc. Insider Trades
| Date | 16 Apr |
| Name | Wallace Cyril Arthur |
| Role | CEO |
| Transaction | Disposed |
| Type | |
| Shares | 0 |
| Date | 4 Jun |
| Name | Era Regenerative Medicine Ltd |
| Role | 10 percent owner |
| Transaction | Acquired |
| Type | P-Purchase |
| Shares | 1075269 |
| Date | 14 Apr |
| Name | Bakker Rudolf Johannes Maria |
| Role | Director |
| Transaction | Disposed |
| Type | |
| Shares | 0 |
| Date | 31 Dec |
| Name | Era Regenerative Medicine Ltd |
| Role | 10 percent owner |
| Transaction | Disposed |
| Type | |
| Shares | 0 |
| Date | 23 May |
| Name | Era Regenerative Medicine Ltd |
| Role | 10 percent owner |
| Transaction | Disposed |
| Type | |
| Shares | 232108 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 16 Apr | Wallace Cyril Arthur | CEO | Disposed | 0 | |
| 4 Jun | Era Regenerative Medicine Ltd | 10 percent owner | Acquired | P-Purchase | 1075269 |
| 14 Apr | Bakker Rudolf Johannes Maria | Director | Disposed | 0 | |
| 31 Dec | Era Regenerative Medicine Ltd | 10 percent owner | Disposed | 0 | |
| 23 May | Era Regenerative Medicine Ltd | 10 percent owner | Disposed | 232108 |